We are live on ! Find out more
ITOS

iTeos Therapeutics
ITOS

Delisted

ITOS was delisted on the 28th of August, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of ITOS yet.

ITOS Hedge Fund Activity: Q4 2025 in Review

0 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in iTeos Therapeutics (ITOS) for Q4 2025, worth a combined $0 — down 100% from $2.35K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of ITOS and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was IFP Advisors, exiting entirely with an estimated $2.35K sold.

  • 0 institutional investors held iTeos Therapeutics (ITOS) as of Q4 2025, down from 1 in Q3 2025.
  • Funds reported $0 of iTeos Therapeutics stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new iTeos Therapeutics positions in Q4 2025 and 1 closed out, a net change of -1 holder.
  • The largest iTeos Therapeutics seller in Q4 2025 was IFP Advisors, an estimated $2.35K sold.

Based on aggregated 13F filings for Q4 2025.